Picture of Cavendish logo

CAV Cavendish News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapContrarian

REG - Cavendish Financial - 2024 Interim Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231219:nRSS2177Xa&default-theme=true

RNS Number : 2177X  Cavendish Financial PLC  19 December 2023

 

Cavendish Financial plc

2024 Interim Results

19 DECEMBER 2023: Cavendish Financial plc (together with its subsidiary
undertakings, "Cavendish" or the "Group") today announces unaudited interim
results for the period ended 30 September 2023.

Julian Morse and John Farrugia, Co-Chief Executive Officers at Cavendish,
said:

"We are delighted with the progress our teams have made in the short time
since the merger in September.  Careful planning enabled rapid business
integration, unlocking £7m of cost synergies, more quickly than we originally
forecast.

We are already winning clients and have executed over 20 transactions across
all divisions since coming together.  Despite the significant one-off costs
of merger, our cash balance had risen to £17m on 30 November.

Perhaps most pleasing has been the positive feedback received from existing
clients, with us achieving our goal of providing enhanced service through our
much deeper resource, efficient business model and renewed energy.  Whilst we
intend to make strategic hires, our teams are settled and we are well
positioned to benefit from improving market conditions when they come."

CAVENDISH - A LEADING UK MID-MARKET INVESTMENT BANK

·    Merger of finnCap Group plc ("finnCap") and Cenkos Securities plc
("Cenkos") legally effective on 7 September 2023

·    Creation of Cavendish, the clear no.1 AIM adviser with over 200
retained corporate clients, serviced by enlarged sector focused teams.

·    Wide product expertise across ECM, private and public M&A, debt
advisory and private capital

·    Enhanced corporate broking, distribution and equity research offering
for all clients

·    Pro forma revenue to 30 September 2023: £19.5m (H1 FY23: £23.3m)

STRONG POST-MERGER PERFORMANCE((1))

·    £7m annualised cost synergies locked in, ahead of and quicker than
our pre-merger plans

·    Effective pre-planning and the subsequent rapid integration of teams,
systems and processes has enabled uninterrupted focus on client service

·    Since completion, Cavendish has been appointed by 3 new premium
listed clients.

·    Over 20 transactions already executed together since becoming the
combined group.

BOARD APPOINTMENT

·    Appointment of Mark Astaire - former Vice Chairman of Investment
Banking and Chairman of Corporate Broking of Barclays Investment Bank as an
independent Non-Executive Director

Capital Strength for investment and challenging market conditions

Post integration costs, the Group has substantial regulatory capital and
liquidity.  After merger costs, dividend and bonus payments, cash at 30
September 2023 was £12.3m.  Cash has risen to £17m at 30 November 2023,
driven by the completion of over 20 transactions in the period.

FINANCIAL OVERVIEW(2))

·    Consolidated results include the results of Cenkos from 7 September
2023.

·    Consolidated revenue: £13.4m (H1 FY23: £16.4m) reflecting lower ECM
and private M&A activity during the summer months across the UK markets.

·    Operating loss: £2.0m (H1 FY23: loss £2.3m)

·    Adjusted loss before tax: £3.6m (H1 FY23: loss £0.5m), see note 9.

·    Loss per share: 0.7p (H1 FY23: loss per share 1.8p)

OUTLOOK

The current interest rate upcycle appears to be nearing completion, but
inflationary pressures, although reduced, remain a risk.  With relatively
higher yields available to investors on cash deposits we continue to see a
drag on market demand for UK growth equity.  This has continued to adversely
impact equity transactions and trading, but private and public M&A
activity remains resilient. The breadth of the service offering was a key
driver for the merger, putting us in a strong position to weather market
conditions. Post-merger enhancements in winning and executing business allied
to a tentative pick up of the markets in the last three months has enabled us
to get off to a good start in the second half. We look forward to building on
this momentum, underpinned by a good pipeline, lower overheads and a strong
cash position.

CONTACTS

Cavendish (Management)
                                              Tel: +44
(0) 20 7220 0500

Julian Morse, Co-Chief Executive
Officer
investor.relations@cavendish (mailto:investor.relations@cavendish) .com

John Farrugia, Co-Chief Executive
Officer

Ben Procter, Chief Financial Officer

Grant Thornton (Nominated Adviser)
                                  Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison

Cavendish (Broker)
 
    Tel: +44 (0) 20 7220 0500

Tim Redfern

Hudson Sandler (PR adviser)
                                              Tel: +44
(0) 20 7796 4133

Dan de Belder/Rebekah Chapman

 

(1)             Post-merger performance covers the period from 7
September 2023 to 30 November 2023.

(2)             Basis of preparation: the results for the six
months to 30 September 2023 includes the consolidation of the results for
Cenkos Securities plc from completion of its merger with finnCap Group plc for
the period from 7 September 2023.

The information contained within this announcement is deemed to constitute
inside information as stipulated under the retained EU law version of the
Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK
law by virtue of the European Union (Withdrawal) Act 2018. The information is
disclosed in accordance with the Company's obligations under Article 17 of the
UK MAR. Upon the publication of this announcement, this inside information is
now considered to be in the public domain.

BUSINESS REVIEW

On 7 September 2023, having received FCA approval, we completed the merger
between Cenkos and finnCap creating Cavendish, a new leading UK Investment
Bank focused on the mid-market and servicing over 200 retained clients.

Since the merger we have been actively engaging with our clients to discuss
the Group's wider range of sector and product expertise to support their
growth ambitions, and it has been pleasing to receive positive feedback from
clients noting enhanced service levels from the significantly enlarged team.

Taking best practices from across the combined firm has already improved our
service offering, both in terms of our day-to-day client engagement and how we
work together on transactions.

Within a few weeks of working together we were already winning new clients and
mandates and we continue to make good progress across the group.  We have
integrated our client facing teams and continue to add talent where we see
opportunities. At the same time we have implemented our headcount cost
reduction where there was duplication and put in place our non-people cost
reduction programme, which has resulted in delivering cost synergies of over
£7m, in excess of our pre-merger target.   We are now making selective
hires, recruiting additional talent to allow us to grow the business as market
conditions ease.

Our first half results only reflect the combined group for 3 weeks of the
reporting period. On a pro forma combined basis from 1 April 2023, we
generated revenues of £19.5m, before leveraging the benefits of our combined
expertise and enhanced service offering.

At the end of the period, we had net assets of £39.4m and cash of £12.3m
which has improved substantially since the half year end reflecting good deal
activity.

MARKET CONDITIONS

Persistent inflationary pressure and associated interest rate rises continued
to hamper investment in the equity of UK quoted growth companies across the
period, reflected in the 11% decrease in the FTSE AIM All Share Index in the
period and by far the lowest levels of new and secondary fund raising in the
last twenty years. In M&A, public company take-over activity is perhaps
the strongest we have seen and, although private equity buyers remain cash
rich, the UK economic environment is impacting on deal timetables.

INVESTMENT BANKING REVENUE ((3))

Investment Banking revenue comprises regular retainer income from corporate
clients and advisory fees earned from ECM, M&A, debt and private placings.

On a reported bases, revenue declined by 18% reflecting the impact of weaker
ECM and M&A market conditions over the summer months. On a pro forma basis
Investment Banking revenues of £16.8m were 19% less than in the prior period.

Despite the challenges of market conditions and managing the complexities of
the merger, we have protected our income from client retainers and executed a
number of client transactions, albeit at lower levels, in both the private
M&A and Equity Capital Markets.

 

                             Pro forma                       Reported
                             6 months ended  6 months ended  6 months ended  6 months ended
                             30 Sep 2023     30 Sep 2022     30 Sep 2023     30 Sep 2022
                             £'000           £'000           £'000           £'000

 Corporate Retainers         6,471           6,203           3,914           3,452
 Advisory Fees               10,287          14,522          8,019           10,983
 Investment Banking Revenue  16,758          20,725          11,933          14,435

 

EQUITIES REVENUE ((3))

Weaker equity issuance and investor demand for UK equities did not detract
from the proactive engagement with institutional clients and the quality of
service we delivered, but did reduce market making profits and commission in
the period.

                   Pro forma                       Reported
                   6 months ended  6 months ended  6 months ended  6 months ended
                   30 Sep 2023     30 Sep 2022     30 Sep 2023     30 Sep 2022
                   £'000           £'000           £'000           £'000

 Equities Revenue  2,768           2,581           1,432           1,917

 

OPERATING EXPENSES

Both firms maintained rigorous cost controls ahead of the merger. Merger
related advisory and severance costs are materially behind us.  Most of the
targeted £7m reduction in annualised operating costs, from co-locating and
eliminating duplicate roles and support services, has already been achieved.

We are now focused on firmwide cost controls, automation and outsourcing to
further reduce our cost base.

                                                   Reported
                                                   6 months ended  6 months ended
                                                   30 Sep 2023     30 Sep 2022
                                                   Unaudited       Unaudited
                                                   £'000           £'000

 Employee benefit expense                          11,855          11,329
 Non-employee costs                                5,663           5,728
 Total administrative expenses                     17,518          17,057

 

 

 

On a reported basis, excluding the incremental operating costs arising from
the merger, the change in administration costs reflects the benefit of the
cost reduction programme implemented in the finnCap Group in Q3 of FY23 with
staff and administration costs being in line with our expectations.

SHAREHOLDER REMUNERATION

The Board is committed to delivering returns for our shareholders.  If we can
build on our strong post-merger performance we will consider dividend payments
with the full year results.

BOARD CHANGES

A separate announcement regarding proposed changes to the Board has been
issued today.

NON-RECURRING COSTS

                                           Pro forma       Reported           Reported
                                           6 months ended  6 months ended     6 months ended
                                30 September 2023          30 September 2023  30 September 2022
                                £'000                      £'000              £'000
 Negative goodwill              (5,771)                    (5,771)            -
 Onerous contracts              1,811                      1,811              -
 Group restructuring            1,031                      620                1,255
 Transaction costs              1,335                      1,115              189
 Non-recurring items            (1,594)                    (2,225)            1,444

 

Negative goodwill reflects the difference between of the fair value of Cenkos'
net assets at merger and the value of the shares issued for the purchase.
Onerous contracts reflect the write down of the property no longer occupied by
Cenkos. Group restructuring is the cost of the headcount reduction programme
and Transaction costs cover the advisory fees relating to the merger.

Further non-recurring items will be reported in H2 relating to completion of
the headcount reduction programme and redundant systems.  Overall, the direct
costs of the merger are estimated to be c.£3.7m and the overall annualised
savings for the Group will be more than £7.0m.

In H1 FY23, the non-recurring items related to the headcount reduction
programme implemented by the Group.

(3)    References to unaudited pro forma revenues reflect the addition of
the unaudited consolidated revenue of finnCap Group plc and the unaudited
consolidated revenue of Cenkos Securities plc for the relevant period as if
they were consolidated fully for that period.  Pro forma information is a
non-GAAP measure and is provided to assist with a better understanding of the
Group's performance.

 

CONSOLIDATED INCOME STATEMENT

Unaudited for the 6 months ended 30 september 2023

                                                                         6 months ended     6 months ended     12 months ended
                                                                         30 September 2023  30 September 2022  31 March 2023
                                                                         Unaudited          Unaudited          Audited
                                                                         £'000              £'000              £'000
                                                                Notes
 Revenue                                                        2        13,365             16,352             32,864
 Other operating expenses                                       3        (90)               (138)              (214)
 Total income                                                            13,275             16,214             32,650
 Administrative expenses                                        4        (17,518)           (17,057)           (34,543)
 Operating loss before non-recurring items                               (4,243)            (843)              (1,893)
 Non-recurring items                                            5        2,225              (1,444)            (3,658)
 Operating loss                                                          (2,018)            (2,287)            (5,551)
 Finance income                                                          73                 22                 65
 Finance charge                                                          (223)              (242)              (502)
 Share of associate and joint venture losses                             (241)              (85)               (297)
 Loss before taxation                                                    (2,409)            (2,592)            (6,285)
 Taxation                                                                1,168              (487)              767
 Loss attributable to equity shareholders                                (1,241)            (3,079)            (5,518)
 Total comprehensive expense for the year                                (1,241)            (3,079)            (5,518)

 Loss per share (pence)
 Basic                                                          6        (0.66)             (1.82)             (3.25)
 Diluted                                                        6        (0.66)             (1.82)             (3.25)

 

 

CONSOLIDATED BALANCE SHEET

Unaudited for the 6 months ended 30 september 2023

                                                          30 September 2023  30 September 2022  31 March 2023
                                                          Unaudited          Unaudited          Audited
                                                          £'000              £'000              £'000
 Non-current assets
 Property, plant and equipment                            11,960             12,518             12,239
 Intangible assets                                        13,534             13,514             13,492
 Investment in associates and joint ventures              1,987              2,218              2,106
 Financial assets held at fair value                      746                729                404
 Deferred tax asset                          8 i)         4,040              133                886
 Total non-current assets                                 32,267             29,112             29,127
 Current assets
 Trade and other receivables                 8 ii)        17,382             11,186             13,186
 Current assets held at fair value                        5,624              213                269
 Cash and cash equivalents                                12,341             11,124             9,382
 Total current assets                                     35,347             22,523             22,837
 Total assets                                             67,614             51,635             51,964

 Non-Current liabilities
 Lease liability                                          10,214             10,829             10,008
 Borrowings                                               291                667                481
 Provisions                                               66                 30                 29
 Total non-Current liabilities                            10,571             11,526             10,518
 Current liabilities
 Trade and other payables                                 17,247             9,122              14,632
 Borrowings                                               414                364                843
 Total current liabilities                                17,661             9,486              15,475
 Equity
 Share capital                                            3,622              1,811              1,811
 Share premium                                            1,716              1,716              1,716
 Own shares held                             8 iii)       (5,090)            (1,926)            (1,926)
 EBT reserve                                              (350)              (338)              (294)
 Merger relief reserve                       8 iv)        25,151             10,482             10,482
 Share based payments reserve                             3,107              1,588              1,771
 Retained earnings                                        11,226             17,290             12,411
 Total equity                                             39,382             30,623             25,971
 Total equity and liabilities                             67,614             51,635             51,964

 

 

CONSOLIDATED STATEMENT OF CHANGE IN EQUITY

Unaudited for the 6 months ended 30 september 2023

                                                               Own               Merger   Share Based
                                             Share    Share    Shares   EBT      Relief   Payment      Retained  Total
                                             Capital  Premium  Held     Reserve  Reserve  Reserve      Earnings  Equity
                                             £'000    £'000    £'000    £'000    £'000    £'000        £'000     £'000
 Balance at 31 March 2022                    1,799    1,475    (1,926)  (322)    10,482   1,294        20,261    33,063
 Total comprehensive expense for the period  -        -        -        (16)     -        -            (3,063)   (3,079)
 Transactions with owners:
 Share based payments charge                 -        -        -        -        -        386          -         386
 Share options exercised                     12       241      -        -        -        (92)         92        253
                                             12       241      -        -        -        294          92        639
 Balance at 30 September 2022                1,811    1,716    (1,926)  (338)    10,482   1,588        17,290    30,623
 Total comprehensive expense for the period  -        -        -        44       -        -            (2,483)   (2,439)
 Transactions with owners:
 Share based payments charge                 -        -        -        -        -        191          -         191
 Deferred tax on share-based payments        -        -        -        -        -        -            (450)     (450)
 Dividends                                   -        -        -        -        -        -            (1,954)   (1,954)
 Share options exercised                     -        -        -        -        -        (8)          8         -
                                             -        -        -        -        -        183          (2,396)   (2,213)
 Balance at 31 March 2023                    1,811    1,716    (1,926)  (294)    10,482   1,771        12,411    25,971
 Total comprehensive expense for the period  -        -        -        (56)     -        -            (1,185)   (1,241)
 Transactions with owners:
 Share based payments charge                 -        -        -        -        -        746          -         746
 Investment in subsidiaries                  1,811    -        (3,164)  -        14,669   590          -         13,906
                                             1,811    -        (3,164)  -        14,669   1,336        -         14,652
 Balance at 30 September 2023                3,622    1,716    (5,090)  (350)    25,151   3,107        11,226    39,382

 

 

CONSOLIDARED STATEMENT OF CASH FLOWS

Unaudited for the 6 months ended 30 september 2023

                                                         6 months ended     6 months ended     12 months ended
                                                         30 September 2023  30 September 2022  31 March 2023
                                                         Unaudited          Unaudited          Audited
                                                         £'000              £'000              £'000
 Cash flows from operating activities
 Loss before taxation                                    (2,409)            (2,592)            (6,285)
 Adjustments for:
 Depreciation                                            919                891                1,789
 Amortisation of intangible assets                       28                 31                 60
 Share of associate and joint venture losses             241                85                 297
 Negative goodwill                                       (5,771)            -                  -
 Onerous contracts                                       1,523              -                  -
 Finance income                                          (73)               (22)               (65)
 Finance charge                                          223                242                502
 Share based payments charge                             746                386                577
 Net fair value gains recognised in profit or loss       90                 138                382
 Payments received of non-cash assets                    -                  (15)               (854)
                                                         (4,483)            (856)              (3,597)
 Changes in working capital:
 (Increase) / decrease in trade and other receivables    (4,196)            1,888              398
 Increase / (decrease) in trade and other payables       1,685              (10,505)           (5,951)
 Increase / (decrease) in provisions                     37                 (64)               (65)
 Acquisition of subsidiary working capital               1,810              -                  -
 Cash utilised from operations                           (5,147)            (9,537)            (9,215)
 Net cash payments for current asset investments
 held at fair value through profit or loss               (1,719)            658                602
 Tax paid                                                -                  (1,141)            (1,155)
 Net cash outflow from operating activities              (6,866)            (10,020)           (9,768)
 Cash flows from investing activities
 Purchase of property, plant and equipment               (109)              (112)              (724)
 Purchase of intangible assets                           (70)               (25)               (40)
 Proceeds on sale of investments                         -                  -                  870
 Acquisition of subsidiary, net of cash acquired         11,576             -                  -
 Investments in associates and joint ventures            (50)               (2,022)            (2,029)
 Interest received                                       73                 22                 65
 Net cash outflow from investing activities              11,420             (2,137)            (1,858)
 Cash flows from financing activities
 Equity dividends paid                                   -                  -                  (1,954)
 Proceeds from exercise of options                       -                  3                  3
 Interest paid                                           (14)               (21)               (38)
 Lease liabilities payments                              (962)              (960)              (1,555)
 Repayment of borrowings                                 (619)              (176)              (356)
 Proceeds from borrowings                                -                  -                  473
 Net cash inflow / (outflow) from financing activities   (1,595)            (1,154)            (3,427)
 Net increase / (decrease) in cash and cash equivalents  2,959              (13,311)           (15,053)
 Cash and cash equivalents at beginning of period        9,382              24,435             24,435
 Cash and cash equivalents at end of period              12,341             11,124             9,382

 

 

NOTES TO THE FINANCIAL STATEMENTS

Unaudited for the 6 months ended 30 september 2023

1.   Basis of preparation

Cavendish Financial plc (the "Company") is a public limited company, limited
by shares, incorporated and domiciled in England and Wales. The Company was
incorporated on 28 August 2018. The registered office of the Company is at 1
Bartholomew Close, London EC1A 7BL, United Kingdom. The registered company
number is 11540126. The Company is quoted on the AIM of the London Stock
Exchange.

The financial Information contained within these condensed consolidated
Interim financial statements Is unaudited and has been prepared in accordance
with International Accounting Standard 34 Interim Financial Reporting ('IAS
34') and AIM Rule 18. The financial information contained in the Interim
Financial Statements is unaudited and does not constitute statutory accounts
within the meaning of Section 434 of the Companies Act 2006.

The statutory accounts for the 12 months ended 31 March 2023 have been
delivered to the Registrar of Companies. The statutory accounts have been
prepared in accordance with International Financial Reporting Standards and
International Accounting Standards as adopted by the European Union and the
IFRS Interpretation Committee interpretations (collectively IFRSs), and in
accordance with applicable law. The Independent Auditor's Report to the
members of finnCap Group plc contained no qualification or statement under
section 498 (2) or (3) of the Companies Act 2006.

These consolidated Interim Financial Statements contain information about the
Group and have been prepared on a historical cost basis except for certain
financial instruments which are carried at fair value. Amounts are rounded to
the nearest thousand, unless otherwise stated and are presented in pounds
sterling, which is the currency of the primary economic environment in which
the Group operates.

The preparation of these Interim Financial Statements requires the use of
certain critical accounting estimates. It also requires Group management to
exercise judgement in applying the Group's accounting policies. Judgements and
estimates used in these Interim Financial Statements have been applied on a
consistent basis with those use in the statutory accounts for the 12 months
ended 31 March 2023.

As normal, the Group has assessed the appropriateness of accounting on a going
concern basis. This process involved the review of a forecast for the coming
15 months, along with stress testing a second downside scenario. Both cases
showed that the Group has the required resources to operate within its
resources during the period.

The Directors believe that the Group has adequate resources to continue
trading for at least 12 months from the date of approval of this report.
Accordingly, they continue to adopt the going concern basis in preparing the
Interim Financial Statements.

2.   Segmental reporting

The Group is managed as an integrated financial services group and the
different revenue streams are considered to be subject to similar economic
characteristics. Consequently, the Group is managed as one business unit.

The trading operations of the Group comprise of Corporate Advisory and
Broking, M&A Advisory and Institutional Stockbroking. The Group's revenues
are derived from activities conducted in the UK, although several of its
corporate and institutional investors and clients are situated overseas. All
assets of the Group reside in the UK.

                                                            6 months ended     6 months ended     12 months ended
                                                            30 September 2023  30 September 2022  31 March 2023
                                                            Unaudited          Unaudited          Audited
                                                            £'000              £'000              £'000
 Revenues
 Retainers                                                  3,914              3,452              6,956
 Transactions                                               8,019              10,983             22,632
 Securities                                                 1,432              1,917              3,276
 Total Revenue                                              13,365             16,352             32,864

 Services transferred at a point in time                    8,665              12,100             24,413
 Services transferred over a period of time                 4,700              4,252              8,451
 Total Revenue                                              13,365             16,352             32,864

 

 

3.   Other operating EXpenses

 

                                      6 months ended     6 months ended     12 months ended
                                      30 September 2023  30 September 2022  31 March 2023
                                      Unaudited          Unaudited          Audited
                                      £'000              £'000              £'000

 Other operating expenses             (90)               (138)              (214)

 

4.   Expenses by Nature

                                           6 months ended     6 months ended     12 months ended
                                           30 September 2023  30 September 2022  31 March 2023
                                           Unaudited          Unaudited          Audited
                                           £'000              £'000              £'000

 Employee benefit expense                  11,855             11,329             23,257
 Non-employee costs                        5,663              5,728              11,286
 Total administrative expenses             17,518             17,057             34,543

 Average number of employees               157                151                155

 

Employee benefit expense includes share based payments of £746k (H1 FY23:
£386k).

 

5.   Non-recurring items

                                        6 months ended     6 months ended     12 months ended
                                        30 September 2023  30 September 2022  31 March 2023
                                        Unaudited          Unaudited          Audited
                                        £'000              £'000              £'000

 Negative goodwill                      (5,771)            -                  -
 Onerous contracts                      1,811              -                  -
 Group restructuring                    620                1,255              3,247
 Transaction fees                       1,115              189                411
 Non-recurring items                    (2,225)            1,444              3,658

 

Non-recurring items in the period relate to negative goodwill, group
restructuring costs, onerous contracts and legal and professional fees in
connection with the acquisition of Cenkos Securities plc on the 7(th)
September 2023, see note 9.

 

 

6.   Earnings per share

                                                                 6 months ended        6 months ended     12 months ended
                                                                 30 September 2023     30 September 2022  31 March 2023
                                                                 Unaudited             Unaudited          Audited
 Earnings per share
 Number of shares
 Weighted average number of shares for the purposes
 of basic earnings per share                                     187,101,924           169,041,783        169,724,785
 Weighted average dilutive effect of conditional share
 awards                                                          2,453,333             3,011,648          11,847,873
 Weighted average number of shares for the purposes
 of diluted earnings per share                                   189,555,257           172,053,431        181,572,658

 Loss per ordinary share (pence)
 Basic loss per ordinary share                                              (0.66)     (1.82)             (3.25)
 Diluted loss per ordinary share                                            (0.66)     (1.82)             (3.25)

 

The shares held by the Group's Employee Benefit Trusts have been excluded from
the calculation of earnings per share.

 

7.   Dividends

                                                        6 months ended     6 months ended     12 months ended
                                                        30 September 2023  30 September 2022  31 March 2023
                                                        Unaudited          Unaudited          Audited
                                                        £'000              £'000              £'000

 Dividends proposed and paid during the year            -                  -                  1,954
 Dividends per share                                    -p                 -p                 1.15p

 

 

8.   Balance Sheet Items

 

i)              Deferred tax asset

Deferred taxation for the group relates to timing difference on the taxation
relief on the exercise of options and tax losses carried forward. The amount
of the asset is determined using tax rates that have been enacted or
substantively enacted when the deferred tax assets are expected to be
recovered.

 

ii)             Trade and other receivables

Trade and other receivable principally consist of amounts due from client,
brokers and other counterparties. In addition, the Group has credit risk
exposure to the gross value of unsettled trades (on a delivery versus payment
basis) at its agency settlement agent (Pershing, a wholly owned subsidiary of
Bank of New York Mellon Corporation).

iii)            Own Shares Held

The value of own shares held is the cost of shares purchased the Group's
Employee Benefit Trusts. The Trusts were established with the authority to
acquire shares in the Group and are funded by the Group.

iv)            Merger relief reserve

The merger relief reserve represents:

·      the difference between net book value of subsidiaries acquired
via share-for-share exchanges and the nominal value of the shares issued as
consideration. Upon consolidation, part of the merger reserve is eliminated to
recognise the pre-acquisition reserves of Cavendish Capital Markets Limited
(December 2018) and Cavendish Securities plc (September 2023); and

·      the difference between the fair value and nominal value of shares
issued for the acquisition of Cavendish Corporate Finance (UK) Limited and
Cavendish Corporate Finance LLP from the acquisition in December 2018.

 

This reserve is not distributable.

 

v)             Post balance sheet events

There are no material post balance sheet events.

 

9.   Acquisition of Cavendish Securites PLC

On 7 September 2023, having received FCA approval, Cavendish Financial plc
issued 181,094,721 shares to acquired 100% of the share capital of Cavendish
Securities plc by means of a scheme of arrangement under Part 26 of the UK
Companies Act 2006 for consideration of £13.9m.

The fair value of the shares issue was calculated using the Cavendish
Financial plc market price of 9.1 pence per share, on the AIM exchange at its
close of business on 6 September 2023. The fair value was increased due to
employee share based awards outstanding at the acquisition date and reduced
due to shares held by the Cavendish Securities plc at the date of the
acquisition.

                                      Book Value          Fair Value   Fair Value
                                      6 September 2023    Adjustments  6 September 2023
 Right of use assets                  3,207               744          3,951
 Deferred tax assets                  2,049               (268)        1,781
 Financial assets held at fair value  467                 -            467
 Other non-current assets             408                 -            408
 Trade and other receivables          8,182               -            8,182
 Current assets held at fair value    3,636               -            3,636
 Cash and cash equivalents            11,576              -            11,576
 Trade and other payables             (10,650)            328          (10,322)
 Net assets acquired                  18,875              804          19,679
 Fair value of equity consideration                                    13,907
 Negative goodwill                                                     (5,772)

 

IFRS3 requires the acquirer to perform a fair value exercise during the
measurement period which can last no more than twelve months from the date of
acquisition. An assessment of intangible assets was performed at the
acquisition as part of the implementation of IFRS 3. No additional assets were
recognised as a result of this review. The acquired right of use assets and
lease liabilities were recognised using the present value of the remaining
lease payments at the acquisition date.

Transactions costs of £1.1m were incurred in relation to the acquisition.

10.  Related party transactions

During the period, 5,000,000 options with a 15p exercise price and 2,000,000
options with a 1p exercise price were issued to John Farrugia, a director of
Cavendish Finance plc. All of the options have a vesting period to two years.

 

11.  Alternative performance measures

 

The below non-GAAP alternative performance measures have been used.

Adjusted profit before tax

Measure: Adjusted profit before tax is calculated excluding share based
payments, non-recurring items, share of associate profits and fair value gains
on long term investments.

Use: Provides a consistent measure of the earnings performance of the core
business activities.

                                                            6 months ended     6 months ended     12 months ended
                                                            30 September 2023  30 September 2022  31 March 2023
                                                            Unaudited          Unaudited          Audited
                                                            £'000              £'000              £'000

 Operating loss                                             (2,018)            (2,287)            (5,551)
 Fair value gains on long term investments                  90                 138                -
 Negative goodwill (see note 9)                             (5,771)            -                  -
 Other non-recurring expenses                               3,546              1,444              3,658
 Share based payments                                       746                386                577
 Net finance charge                                         (150)              (220)              (232)
 Amortisation                                               -                  -                  59
 Adjusted loss before tax                                   (3,557)            (539)              (1,489)

 

Pro forma Revenues

References to unaudited pro forma revenues reflect the addition of the
unaudited consolidated revenue of finnCap Group plc and the unaudited
consolidated revenue of Cenkos Securities plc for the relevant period as if
they were consolidated fully for that period.  Pro forma information is a
non-GAAP measure and is provided to assist with a better understanding of the
Group's performance.

INDEPENDENT REVIEW REPORT TO CAVENDISH FINANCIAL PLC

Unaudited for the 6 months ended 30 september 2023

Conclusion

Based on our review, nothing has come to our attention that causes us to
believe that the condensed set of financial statements in the half-yearly
financial report for the six months ended 30 September 2023 is not prepared,
in all material respects, in accordance with UK adopted International
Accounting Standard 34 and the London Stock Exchange AIM Rules for Companies.

We have been engaged by the company to review the condensed set of financial
statements in the half-yearly financial report for the six months ended 30
September 2023 which comprises the condensed Income Statement, the condensed
Statement of Comprehensive Income, the condensed Statement of Financial
Position, the condensed Cash Flow Statement and the condensed Statement of
Changes in Equity and all accompanying notes.

Basis for conclusion

We conducted our review in accordance with International Standard on Review
Engagements (UK) 2410, "Review of Interim Financial Information Performed by
the Independent Auditor of the Entity" ("ISRE (UK) 2410"). A review of interim
financial information consists of making enquiries, primarily of persons
responsible for financial and accounting matters, and applying analytical and
other review procedures. A review is substantially less in scope than an audit
conducted in accordance with International Standards on Auditing (UK) and
consequently does not enable us to obtain assurance that we would become aware
of all significant matters that might be identified in an audit. Accordingly,
we do not express an audit opinion.

As disclosed in note 1, the annual financial statements of the group are
prepared in accordance with UK adopted international accounting standards. The
condensed set of financial statements included in this half-yearly financial
report has been prepared in accordance with UK adopted International
Accounting Standard 34, "Interim Financial Reporting."

Conclusions relating to going concern

Based on our review procedures, which are less extensive than those performed
in an audit as described in the Basis for conclusion section of this report,
nothing has come to our attention to suggest that the directors have
inappropriately adopted the going concern basis of accounting or that the
directors have identified material uncertainties relating to going concern
that are not appropriately disclosed.

This conclusion is based on the review procedures performed in accordance with
ISRE (UK) 2410, however future events or conditions may cause the group to
cease to continue as a going concern.

 

 

Responsibilities of directors

The directors are responsible for preparing the half-yearly financial report
in accordance with

the London Stock Exchange AIM Rules for Companies which require that the
half-yearly report be presented and prepared in a form consistent with that
which will be adopted in the Company's annual accounts having regard to the
accounting standards applicable to such annual accounts.

In preparing the half-yearly financial report, the directors are responsible
for assessing the company's ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and using the
going concern basis of accounting unless the directors either intend to
liquidate the company or to cease operations, or have no realistic alternative
but to do so.

Auditor's responsibilities for the review of the financial information

In reviewing the half-yearly report, we are responsible for expressing to the
Company a conclusion on the condensed set of financial statement in the
half-yearly financial report. Our conclusion, including our Conclusions
Relating to Going Concern, are based on procedures that are less extensive
than audit procedures, as described in the Basis for Conclusion paragraph of
this report.

Use of our report

Our report has been prepared in accordance with the terms of our engagement to
assist the Company in meeting the requirements of the rules of the London
Stock Exchange AIM Rules for Companies for no other purpose.  No person is
entitled to rely on this report unless such a person is a person entitled to
rely upon this report by virtue of and for the purpose of our terms of
engagement or has been expressly authorised to do so by our prior written
consent.  Save as above, we do not accept responsibility for this report to
any other person or for any other purpose and we hereby expressly disclaim any
and all such liability.

 

BDO LLP

Chartered Accountants

London, UK

Date 18 December 2023

BDO LLP is a limited liability partnership registered in England and Wales
(with registered number OC305127).

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR EAEAPFAEDFAA

Recent news on Cavendish

See all news